|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas and Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar
|
|
3
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar
|
|
4
|
Borczuk AC: Prognostic considerations of
the new world health organization classification of lung
adenocarcinoma. Eur Respir Rev. 25:364–371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhong X, Liu L, Zhao A, Pfeifer GP and Xu
X: The abnormal spindle-like, microcephaly-associated (ASPM) gene
encodes a centrosomal protein. Cell Cycle. 4:1227–1229. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kouprina N, Pavlicek A, Mochida GH,
Solomon G, Gersch W, Yoon YH, Collura R, Ruvolo M, Barrett JC,
Woods CG, et al: Accelerated evolution of the ASPM gene controlling
brain size begins prior to human brain expansion. PLoS Biol.
2:E1262004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Passemard S, Titomanlio L, Elmaleh M,
Afenjar A, Alessandri JL, Andria G, Billette de Villemeur T,
Boespflug-Tanguy O, Burglen L, Del Giudice E, et al: Expanding the
clinical and neuroradiologic phenotype of primary microcephaly due
to ASPM mutations. Neurology. 73:962–969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Capecchi MR and Pozner A: ASPM regulates
symmetric stem cell division by tuning Cyclin E ubiquitination. Nat
Commun. 6:87632015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gai M, Bianchi FT, Vagnoni C, Verni F,
Bonaccorsi S, Pasquero S, Berto GE, Sgrò F, Chiotto AA, Annaratone
L, et al: ASPM and CITK regulate spindle orientation by affecting
the dynamics of astral microtubules. EMBO Rep. 18:18702017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang K, Rezabkova L, Hua S, Liu Q,
Capitani G, Altelaar AFM, Heck AJR, Kammerer RA, Steinmetz MO and
Akhmanova A: Microtubule minus-end regulation at spindle poles by
an ASPM-katanin complex. Nat Cell Biol. 19:480–492. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
An X, Huang Y and Zhao P: Expression of
ASPM in colonic adenocarcinoma and its clinicopathologic
significance. Int J Clin Exp Pathol. 10:8968–8973. 2017.PubMed/NCBI
|
|
12
|
Chen X, Huang L, Yang Y, Chen S, Sun J, Ma
C, Xie J, Song Y and Yang J: ASPM promotes glioblastoma growth by
regulating G1 restriction point progression and Wnt-β-catenin
signaling. Aging (Albany NY). 12:224–241. 2020. View Article : Google Scholar
|
|
13
|
Xie JJ, Zhuo YJ, Zheng Y, Mo RJ, Liu ZZ,
Li BW, Cai ZD, Zhu XJ, Liang YX, He HC and de Zhong W: High
expression of ASPM correlates with tumor progression and predicts
poor outcome in patients with prostate cancer. Int Urol Nephrol.
49:817–823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Timaner M and Shaked Y: Elucidating the
roles of ASPM isoforms reveals a novel prognostic marker for
pancreatic cancer. J Pathol. 250:123–125. 2020. View Article : Google Scholar
|
|
15
|
Alsiary R, Bruning-Richardson A, Bond J,
Morrison EE, Wilkinson N and Bell SM: Deregulation of microcephalin
and ASPM expression are correlated with epithelial ovarian cancer
progression. PLoS One. 9:e970592014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC,
Peng SY, Lai PL and Hsu HC: ASPM is a novel marker for vascular
invasion, early recurrence, and poor prognosis of hepatocellular
carcinoma. Clin Cancer Res. 14:4814–4820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Z, Zhang Q, Luh F, Jin B and Liu X:
Overexpression of the ASPM gene is associated with aggressiveness
and poor outcome in bladder cancer. Oncol Lett. 17:1865–1876.
2019.PubMed/NCBI
|
|
18
|
Chansky K, Detterbeck FC, Nicholson AG,
Rusch VW, Vallieres E, Groome P, Kennedy C, Krasnik M, Peake M,
Shemanski L, et al: The IASLC lung cancer staging project: External
validation of the revision of the TNM stage groupings in the eighth
edition of the TNM classification of lung cancer. J Thorac Oncol.
12:1109–1121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang J, Li H, Han J, Jiang J, Wang J, Li
Y, Feng Z, Zhao R, Sun Z, Lv B and Tian H: Mex3a interacts with
LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT
pathway. Cell Death Dis. 11:6142020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moreno Leon L, Gautier M, Allan R, Ilie M,
Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al:
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA
contributes to an aggressive phenotype in lung adenocarcinoma
through regulation of oxidative stress. Oncogene. 38:7146–7165.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar
|
|
23
|
Director's Challenge Consortium for the
Molecular Classification of Lung Adenocarcinoma; Shedden K, Taylor
JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S,
Jurisica I, Giordano TJ, et al: Gene expression-based survival
prediction in lung adenocarcinoma: A multi-site, blinded validation
study. Nat Med. 14:822–827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar
|
|
26
|
Yeo W, Chan SL, Mo FK, Chu CM, Hui JW,
Tong JH, Chan AWH, Koh J, Hui EP, Loong H, et al: Phase I/II study
of temsirolimus for patients with unresectable hepatocellular
carcinoma (HCC)-a correlative study to explore potential biomarkers
for response. BMC Cancer. 15:3952015. View Article : Google Scholar
|
|
27
|
Azim HA Jr, Peccatori FA, Brohee S,
Branstetter D, Loi S, Viale G, Piccart M, Dougall WC, Pruneri G and
Sotiriou C: RANK-ligand (RANKL) expression in young breast cancer
patients and during pregnancy. Breast Cancer Res. 17:242015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su D, Liao Z, Feng B, Wang T, Shan B, Zeng
Q, Song J and Song Y: Pulsatilla chinensis saponins cause liver
injury through interfering ceramide/sphingomyelin balance that
promotes lipid metabolism dysregulation and apoptosis.
Phytomedicine. 76:1532652020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shan B, Ai Z, Zeng S, Song Y, Song J, Zeng
Q, Liao Z, Wang T, Huang C and Su D: Gut microbiome-derived lactate
promotes to anxiety-like behaviors through GPR81 receptor-mediated
lipid metabolism pathway. Psychoneuroendocrinology. 117:1046992020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:49472019. View Article : Google Scholar :
|
|
33
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oudkerk M, Liu S, Heuvelmans MA, Walter JE
and Field JK: Lung cancer LDCT screening and mortality
reduction-evidence, pitfalls and future perspectives. Nat Rev Clin
Oncol. 18:135–151. 2021. View Article : Google Scholar
|
|
35
|
Li Z, Qi F and Li F: Establishment of a
gene signature to predict prognosis for patients with lung
adenocarcinoma. Int J Mol Sci. 21:84792020. View Article : Google Scholar :
|
|
36
|
Li L, Peng M, Xue W, Fan Z, Wang T, Lian
J, Zhai Y, Lian W, Qin D and Zhao J: Integrated analysis of
dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of
lung adenocarcinoma. J Transl Med. 16:3722018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu CC, Liao WY, Chan TS, Chen WY, Lee CT,
Shan YS, Huang PJ, Hou YC, Li CR and Tsai KK: The differential
distributions of ASPM isoforms and their roles in Wnt signaling,
cell cycle progression, and pancreatic cancer prognosis. J Pathol.
249:498–508. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang J, Lu M, Cui Q, Zhang D, Kong D, Liao
X, Ren J, Gong Y and Wu G: Overexpression of ASPM, CDC20, and TTK
confer a poorer prognosis in breast cancer identified by gene
co-expression network analysis. Front Oncol. 9:3102019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou JW, Wang H, Sun W, Han NN and Chen L:
ASPM is a predictor of overall survival and has therapeutic
potential in endometrial cancer. Am J Transl Res. 12:1942–1953.
2020.PubMed/NCBI
|
|
40
|
Bikeye SN, Colin C, Marie Y, Vampouille R,
Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud
P, et al: ASPM-associated stem cell proliferation is involved in
malignant progression of gliomas and constitutes an attractive
therapeutic target. Cancer Cell Int. 10:12010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yuan YJ, Sun Y, Gao R, Yin ZZ, Yuan ZY and
Xu LM: Abnormal spindle-like microcephaly-associated protein (ASPM)
contributes to the progression of lung squamous cell carcinoma
(LSCC) by regulating CDK4. J Cancer. 11:5413–5423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Santamaria PG, Moreno-Bueno G, Portillo F
and Cano A: EMT: Present and future in clinical oncology. Mol
Oncol. 11:718–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aiello NM and Kang Y: Context-dependent
EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Karimi Roshan M, Soltani A, Soleimani A,
Rezaie Kahkhaie K, Afshari AR and Soukhtanloo M: Role of AKT and
mTOR signaling pathways in the induction of epithelial-mesenchymal
transition (EMT) process. Biochimie. 165:229–234. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Papadimitrakopoulou V: Development of
PI3K/AKT/mTOR pathway inhibitors and their application in
personalized therapy for non-small-cell lung cancer. J Thorac
Oncol. 7:1315–1326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang F, Li J, Liu J and Zhao Q:
Controversial role of the possible oxyntic stem cell marker ASPM in
gastric cancer. J Pathol. 241:559–561. 2017. View Article : Google Scholar
|
|
47
|
Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP,
Chen WY, Li CR, Lin CY, Huang SP, Chen LT and Tsai KK: ASPM
promotes prostate cancer stemness and progression by augmenting
Wnt-Dvl-3-β-catenin signaling. Oncogene. 38:1340–1353. 2019.
View Article : Google Scholar
|
